CLINICAL_TRIALS
trial_result
· 2025-05-01
Clinical Trial Update: A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma [Phase 3]
Summary
Phase 3 non-inferiority trial comparing Foraseq (budesonide/formoterol) to Alenia in asthma has completed with results posted on 2025-05-01.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eurofarma Laboratorios S.A. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2025-05-01